Results 91 to 100 of about 87,039 (290)

Machine Learning-Based Analysis of ECG and PCG Signals for Rheumatic Heart Disease Detection: A Scoping Review (2015-2025) [PDF]

open access: yesarXiv
Objective: To conduct a systematic assessment of machine learning applications that utilize electrocardiogram (ECG) and heart sound data in the development of cost-effective detection tools for rheumatic heart disease (RHD) from the year 2015 to 2025, thereby supporting the World Heart Federation's "25 by 25" mortality reduction objective through the ...
arxiv  

Heart Disease Prediction System using Associative Classification and Genetic Algorithm [PDF]

open access: yesVol no1 pp 183-192, Elsevier Dec 2012, 2013
Associative classification is a recent and rewarding technique which integrates association rule mining and classification to a model for prediction and achieves maximum accuracy. Associative classifiers are especially fit to applications where maximum accuracy is desired to a model for prediction.
arxiv  

Rheumatic Heart Disease in Asia [PDF]

open access: yesCirculation, 2008
A few years ago, my colleagues and I conducted a systematic review of data relating to the global burden of group A streptococcal diseases.1,2 Population-based data on rheumatic heart disease prevalence from 1985 through 2002 were included. We estimated that there were a minimum of 15.6 million people in the world with rheumatic heart disease, with 282
openaire   +2 more sources

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To assess the value of serum type I interferon (IFN) score in predicting clinically meaningful progression in limited cutaneous systemic sclerosis (lcSSc) using a novel composite endpoint adopted from the MINIMISE clinical trial. Methods A retrospective, longitudinal lcSSc cohort was identified within a national, multicenter observational ...
Stefano Di Donato   +9 more
wiley   +1 more source

CURRENT STA TUS OF RHEUMA TIC FEVER AND RHEUMA TIC HEART DISEASE IN NEPAL

open access: yesJournal of Nepal Medical Association, 2003
Rheumatic fever (RF) and rheumatic heart disease (RHD) are common in underdeveloped, deprived and depressed areas of the world. The progression of RHD is rapid in deprived communuties.
Yuba Raj Limbu, A Maskey
doaj   +1 more source

Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective The sparse effector “omnigenic” hypothesis postulates that the polygenic effects of common single nucleotide polymorphisms (SNPs) on a typical complex trait are mediated by trans effects that coalesce on expression of a relatively sparse set of core genes.
Athina Spiliopoulou   +9 more
wiley   +1 more source

Fibrinous Pericardial Effusion and Valvulitis Secondary to Previous Acute Rheumatic Fever: An Unusual Clinical Presentation

open access: yesGüncel Pediatri, 2014
Rheumatic heart disease, a sequela to acute rheumatic fever (ARF), is a major cause of acquired heart disease in children and young adults in developing countries.
Osman Yılmaz   +2 more
doaj   +1 more source

Deep-learning models improve on community-level diagnosis for common congenital heart disease lesions [PDF]

open access: yesarXiv, 2018
Prenatal diagnosis of tetralogy of Fallot (TOF) and hypoplastic left heart syndrome (HLHS), two serious congenital heart defects, improves outcomes and can in some cases facilitate in utero interventions. In practice, however, the fetal diagnosis rate for these lesions is only 30-50 percent in community settings. Improving fetal diagnosis of congenital
arxiv  

Clinical Factors Associated With Pneumocystis Pneumonia Despite Its Primary Prophylaxis: When to Stop Prophylaxis?

open access: yesArthritis &Rheumatology, EarlyView.
Objective Although previous studies show that primary prophylaxis against Pneumocystis jirovecii pneumonia (PJP) is effective in patients with rheumatic diseases receiving immunosuppressive treatment, there is limited evidence regarding the optimal timing for prophylaxis withdrawal.
Ju Yeon Kim   +5 more
wiley   +1 more source

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

open access: yesArthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Home - About - Disclaimer - Privacy